Regulation of E-cadherin: does hypoxia initiate the metastatic cascade?

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 395697)

Published in Mol Pathol on August 01, 1999

Authors

I R Beavon1

Author Affiliations

1: Department of Anatomical Pathology, School of Pathology, South African Institute for Medical Research, Johannesburg, South Africa. nesinsa@global.co.za

Articles citing this

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol (2003) 2.18

Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A (2006) 1.79

Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci U S A (2006) 1.67

The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem (2009) 1.56

Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci U S A (2009) 1.43

The mechanisms by which polyamines accelerate tumor spread. J Exp Clin Cancer Res (2011) 1.30

E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res (2001) 1.17

Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia (2009) 1.05

Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Mol Carcinog (2011) 0.94

Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma. Virchows Arch (2006) 0.88

Effect of laparotomy and CO(2) pneumoperitoneum on tumor growth of human colon carcinoma and expression pattern of tumor-associated proteins in the SCID mouse. Int J Colorectal Dis (2003) 0.82

Influence of acute hypoxia and radiation quality on cell survival. J Radiat Res (2013) 0.81

Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. Biochem J (2002) 0.80

Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Acta Pharmacol Sin (2011) 0.79

Cell adhesion molecules. Sticky moments in the clinic. BMJ (1999) 0.75

Articles cited by this

(truncated to the top 100)

Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38

Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60

Functional interaction of beta-catenin with the transcription factor LEF-1. Nature (1996) 15.88

The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J (1989) 10.05

Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73

APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50

Association of the APC gene product with beta-catenin. Science (1993) 8.20

Association of the APC tumor suppressor protein with catenins. Science (1993) 7.17

Structural basis of cell-cell adhesion by cadherins. Nature (1995) 6.56

Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A (1990) 5.83

Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta (1994) 5.81

Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol (1993) 5.22

Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol (1994) 5.03

Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res (1996) 4.98

The matrix-degrading metalloproteinases. Bioessays (1992) 4.84

Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci (1994) 4.81

Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul (1989) 4.72

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (1997) 4.55

Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol (1994) 4.46

E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol (1994) 4.34

Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin. J Cell Biol (1994) 4.30

Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol (1997) 4.27

Biological diversity in metastatic neoplasms: origins and implications. Science (1982) 3.95

Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol (1994) 3.66

The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc Natl Acad Sci U S A (1991) 3.62

Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol (1994) 3.61

WNTs modulate cell fate and behavior during vertebrate development. Trends Genet (1997) 3.44

Oncoprotein networks. Cell (1997) 3.42

Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science (1998) 3.39

The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25

Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science (1995) 3.23

Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci U S A (1995) 3.15

Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res (1993) 3.05

Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol (1992) 2.91

Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res (1992) 2.89

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol (1993) 2.84

Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol (1993) 2.74

Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res (1994) 2.65

Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol (1992) 2.65

Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol (1995) 2.64

Assembly of the tight junction: the role of diacylglycerol. J Cell Biol (1993) 2.61

Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res (1994) 2.61

Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure. J Biol Chem (1991) 2.58

E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55

Biology of tumour metastasis. Lancet (1992) 2.44

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res (1994) 2.34

Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol (1995) 2.32

Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol (1998) 2.30

Expression sequences of cell adhesion molecules. Proc Natl Acad Sci U S A (1985) 2.28

A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. Cell Adhes Commun (1994) 2.27

Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A (1988) 2.25

Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol (1994) 2.21

A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res (1994) 2.17

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15

Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol (1990) 2.14

Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst (1990) 2.12

Vectorial targeting of an endogenous apical membrane sialoglycoprotein and uvomorulin in MDCK cells. J Cell Biol (1990) 2.12

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res (1993) 2.09

Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol (1995) 2.03

The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or alpha-catenin. Mol Cell Biol (1995) 1.96

Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res (1993) 1.96

E-cadherin mediated adhesion system in cancer cells. Cancer (1996) 1.94

E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol (1996) 1.86

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol (1993) 1.83

Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet (1994) 1.81

Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol (1993) 1.72

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol (1994) 1.64

Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol (1993) 1.63

E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res (1994) 1.61

Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev (1998) 1.61

Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61

Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1986) 1.61

Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res (1994) 1.58

Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation (1988) 1.55

Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta (1991) 1.53

Topology of cell adhesion molecules. Proc Natl Acad Sci U S A (1989) 1.52

Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol (1994) 1.51

Genetic steps in colorectal cancer. Nat Genet (1994) 1.48

Distinct cadherin-catenin complexes in Ca(2+)-dependent cell-cell adhesion. FEBS Lett (1994) 1.46

Cloning of the human alpha-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem Biophys Res Commun (1993) 1.43

Oncogenes and the strategy of growth factors. Cell (1994) 1.41

Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics (1995) 1.40

Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin Exp Metastasis (1997) 1.37

Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol (1995) 1.36

Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer (1994) 1.36

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer (1998) 1.35

The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A (1995) 1.34

Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer (1997) 1.25

Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer (1994) 1.24

E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer (1993) 1.23

Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest (1997) 1.22

Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Cancer Res (1986) 1.20

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci (1992) 1.19

E-cadherin expression during the differentiation of human trophoblasts. Development (1991) 1.16

E-cadherin expression in intestinal epithelium. J Clin Pathol (1995) 1.15

Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch (1997) 1.12

Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Rev (1990) 1.12

Recent developments in our understanding of gastric lymphomas. Am J Surg Pathol (1996) 1.12